Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Enke

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 25, 2025
Biodistribution and Radiation Dosimetry of [<sup>68</sup>Ga]Ga-RAYZ-8009, a Glypican 3-Targeting Compound for Imaging of Hepatocellular CarcinomaOliver Viering, Julia Brosch-Lenz, Ralph A Bundschuh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 2, 2024
First Safety and Efficacy Data with the Radiohybrid <sup>177</sup>Lu-rhPSMA-10.1 for the Treatment of Metastatic Prostate CancerAlexander Dierks, Alexander Gäble, Andreas Rinscheid, et al.
Neuro-Oncology|June 3, 2026
Spatial dissection of ADC/RPT targets defines heterogeneous expression landscapes and therapeutic implications in rhabdoid tumorsNic G Reitsam, Victoria E Fincke, Maria Daniela Hernandez Ramirez, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2025
Biodistribution and Radiation Dosimetry for [<sup>68</sup>Ga]Ga-LNTH-1363S, a Probe Targeting Fibroblast Activation Protein αJohanna S Enke, Bradley W Schuller, Lisa Glantschnig, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 17, 2025
Comprehensive Characterization via Molecular Imaging, Longitudinal Multisite Sampling, and Autoptic Work-up in Advanced Small Cell Lung Cancer Undergoing SSTR-Directed Radiopharmaceutical TherapyJohanna S Enke, Nic G Reitsam, Sebastian Dintner, et al.
Acta Neuropathologica|January 27, 2026
FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational studyNic G Reitsam, Alexander Gäble, Lisa Siebenhüter, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 3, 2024
Experience of rescue therapy with [<sup>177</sup>Lu]Lu-rhPSMA-10.1 in patients with primary or acquired resistance to [<sup>177</sup>Lu]Lu-PSMA-I&TAlexander Gäble, Alexander Dierks, Andreas Rinscheid, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2024
C-X-C Motif Chemokine Receptor 4-Directed Scintigraphy Using [<sup>99m</sup>Tc]Tc-Pentixatec in Primary Aldosteronism: A Proof-of-Concept StudyJohanna S Enke, Kathrin Ritzel, Evelyn Asbach, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 5, 2026
Initial Clinical Experience with [<sup>177</sup>Lu]Lu-RTX-2358 Radiopharmaceutical Therapy Targeting Fibroblast Activation Protein: Biodistribution, Pharmacokinetics, and DosimetryLisa Glantschnig, Johanna S Enke, Bradley W Schuller, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 13, 2025
[<sup>99m</sup>Tc]Tc-PSMA-HSG for PSMA-targeted Hybrid Surgical Guidance: a new addition to the PSMA-I&S/I&T familyMargret Schottelius, David Viertl, Tessa Buckle, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 25, 2025
Biodistribution and Radiation Dosimetry of [<sup>68</sup>Ga]Ga-RAYZ-8009, a Glypican 3-Targeting Compound for Imaging of Hepatocellular CarcinomaOliver Viering, Julia Brosch-Lenz, Ralph A Bundschuh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 2, 2024
First Safety and Efficacy Data with the Radiohybrid <sup>177</sup>Lu-rhPSMA-10.1 for the Treatment of Metastatic Prostate CancerAlexander Dierks, Alexander Gäble, Andreas Rinscheid, et al.
Neuro-Oncology|June 3, 2026
Spatial dissection of ADC/RPT targets defines heterogeneous expression landscapes and therapeutic implications in rhabdoid tumorsNic G Reitsam, Victoria E Fincke, Maria Daniela Hernandez Ramirez, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2025
Biodistribution and Radiation Dosimetry for [<sup>68</sup>Ga]Ga-LNTH-1363S, a Probe Targeting Fibroblast Activation Protein αJohanna S Enke, Bradley W Schuller, Lisa Glantschnig, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 17, 2025
Comprehensive Characterization via Molecular Imaging, Longitudinal Multisite Sampling, and Autoptic Work-up in Advanced Small Cell Lung Cancer Undergoing SSTR-Directed Radiopharmaceutical TherapyJohanna S Enke, Nic G Reitsam, Sebastian Dintner, et al.
Acta Neuropathologica|January 27, 2026
FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational studyNic G Reitsam, Alexander Gäble, Lisa Siebenhüter, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 3, 2024
Experience of rescue therapy with [<sup>177</sup>Lu]Lu-rhPSMA-10.1 in patients with primary or acquired resistance to [<sup>177</sup>Lu]Lu-PSMA-I&TAlexander Gäble, Alexander Dierks, Andreas Rinscheid, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2024
C-X-C Motif Chemokine Receptor 4-Directed Scintigraphy Using [<sup>99m</sup>Tc]Tc-Pentixatec in Primary Aldosteronism: A Proof-of-Concept StudyJohanna S Enke, Kathrin Ritzel, Evelyn Asbach, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 5, 2026
Initial Clinical Experience with [<sup>177</sup>Lu]Lu-RTX-2358 Radiopharmaceutical Therapy Targeting Fibroblast Activation Protein: Biodistribution, Pharmacokinetics, and DosimetryLisa Glantschnig, Johanna S Enke, Bradley W Schuller, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 13, 2025
[<sup>99m</sup>Tc]Tc-PSMA-HSG for PSMA-targeted Hybrid Surgical Guidance: a new addition to the PSMA-I&S/I&T familyMargret Schottelius, David Viertl, Tessa Buckle, et al.
Pageof 2